S. Nenan et al., Inhibition of inflammatory cell recruitment by the tachykinin NK3-receptorantagonist, SR 142801, in a murine model of asthma, EUR J PHARM, 421(3), 2001, pp. 201-205
Several observations suggest that tachykinins (substance P, neurokinin A an
d neurokinin B) are involved in the pathogenesis of pulmonary diseases and
elicit several airway responses such as bronchoconstriction and neurogenic
inflammation via interactions with specific receptors denoted NK,, NK, and
NK,. We have investigated the effect of a selective antagonist for tachykin
in NK, receptor. SR 142801 ((R)-(N)-(1-(3-(1-benzoyl-3-(3,4-dichlorophenyl)
piperidin-3-yl)propyl)-4-phenylpiperidin-4-yl-N-methylacetamide)), on the i
nflammatory cell recruitment in ovalbumin-sensitized acid -challenged mice
used as a model of allergic asthma. Twenty hours after the two-ovalbumin ch
allenges, differential cell counts were calculated and indicated that SR 14
2801 caused a significant decrease in the number of neutrophils and eosinop
hils. Forty hours after the last ovalbumin exposure, SR 142801 induced a si
gnificant decrease in the recruitment of eosinophils. These results suggest
that tachykinins and tachykinin NK, receptors can interfere with cell recr
uitment in inflammatory response. (C) 2001 Elsevier Science B.V. All rights
reserved.